UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

UCLA Rheumatology


About Us

UCLA Rheumatology is ranked in the Top 10 across the nation by U.S. News & World Report. Patients are seen at Westwood and Santa Monica campuses. The Division of Rheumatology welcomes referrals of patients for consultative, diagnostic and therapeutic services for both outpatient and inpatient care. Our rheumatologists provide consultation, diagnosis and treatment for simple to complex rheumatic diseases, including general rheumatology and arthritis, lupus, scleroderma, myositis, gout and osteoarthritis. In addition to providing a full range of advanced and effective conventional therapies, UCLA integrates complementary methods such as acupuncture to treat rheumatology patients. 

The UCLA Division of Rheumatology has an active research and clinical practice.  Major areas of research include systemic lupus erythematosus, systemic sclerosis, anti-phospholipid syndrome, atherosclerosis and rheumatoid arthritis.   We are currently participation in more than 20 clinical trials to test modern and brand new therapies in rheumatoid arthritis, systemic lupus erythematosus, scleroderma and psoriatic arthritis.  We are negotiating to participate in additional trials in 2015, hoping to expand into additional problems such as osteoarthritis, vasculitis, gout, lupus, rheumatoid arthritis, and scleroderma.  A special note of thanks to those of you who have participated in these clinical trials, helping us bring new, better treatments to our community, nation and world.  For further information, please refer to the Rheumatology Research Website.

To name a few research achievements from recent years, we have discovered:

  1. New genes and gene regions that predispose to lupus or rheumatoid arthritis; we are dedicated to understanding how they work.
  2. A novel set of biomarkers that predict accelerated atherosclerosis
  3. The hormone leptin (from fat cells) promotes autoimmunity
  4. Ultrasound studies of joints identify people with hidden joint inflammation
  5. A specialized cell in the skin can be manipulated to protect mice from severe lupus dermatitis. Thanks again to all of you who gave blood, DNA, and information to support our research efforts.

Education is one of our main focus in Rheumatology. UCLA Rheumatologists have chaired the preparation of national guidelines for prevention of steroid-induced bone loss (osteoporosis), for treatment of lupus nephritis, and will soon release guidelines for treatment of gout. (Rheumatoid arthritis and scleroderma guidelines were done last year). This work has local, national and international impact: our colleagues in the media have been disseminating these educational products world-wide. The guidelines have been or soon will be published in the official journal of the American College of Rheumatology. All have been presented at national Rheumatology meetings, with the meeting rooms overflowing with physicians wanting to learn it. We continue to attract top graduates from medical schools and internal medicine programs to train with us as Fellows. Thanks again to all of you who work with these Fellows when you come for your appointments. All of the Residents in Internal Medicine also study with us - thanks again to you who have worked with them. Several of us are preparing new editions of textbooks in rheumatic diseases.

In summary, we continue to thrive in our areas of research, education, and clinical practice.   Again - we give you special thanks for your support. If you would like to make a contribution, please visit our website, http://giving.ucla.edu/rheumatology or contact any of your Rheumatologists at 310-825-7992 or at sedelgado@mednet.ucla.edu

Thank you for supporting UCLA Rheumatology by allowing us to assist in your health care.


UCLA Rated One of the Top Hospitals in the Nation